TY - JOUR
T1 - A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia
AU - Chappell, Amy S
AU - Littlejohn, Geoffrey Owen
AU - Kajdasz, Daniel K
AU - Scheinberg, Morton
AU - D'Souza, Deborah
AU - Moldofsky, Harvey
PY - 2009
Y1 - 2009
N2 - Objectives: Evaluate the efficacy and safety of duloxetine at doses
up to 120mg once daily in patients with fibromyalgia.
Methods: This was a phase 3, 60-week study, which included an
8-week open-label period followed by a 52-week, randomized,
double-blind period. Patients received duloxetine 30mg daily for 1
week and duloxetine 60mg daily for 7 weeks and were then
randomized to receive either 60 or 120mg daily (1:2 ratio).
AB - Objectives: Evaluate the efficacy and safety of duloxetine at doses
up to 120mg once daily in patients with fibromyalgia.
Methods: This was a phase 3, 60-week study, which included an
8-week open-label period followed by a 52-week, randomized,
double-blind period. Patients received duloxetine 30mg daily for 1
week and duloxetine 60mg daily for 7 weeks and were then
randomized to receive either 60 or 120mg daily (1:2 ratio).
UR - http://www.ncbi.nlm.nih.gov/pubmed/19454869
U2 - 10.1097/AJP.0b013e31819be587
DO - 10.1097/AJP.0b013e31819be587
M3 - Article
SN - 0749-8047
VL - 25
SP - 365
EP - 375
JO - The Clinical Journal of Pain
JF - The Clinical Journal of Pain
IS - 5
ER -